Pulse Biosciences (PLSE) News
NASDAQ: PLSEHealth CareMedical/Dental InstrumentsUSD
45.55+1.14 (+2.57%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PLSE news summary
We found 9 recent headlines mentioning Pulse Biosciences (PLSE): 1 in the past week and 6 in the past 30 days, most often from Nasdaq, Business Wire, Seeking Alpha. For price context, PLSE is up 2.57% at $45.55. The most recent story, "Buy 3 Medical Device Stocks for a Stable Portfolio With Solid Upside", was published by Nasdaq on Nov 20, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Pulse Biosciences headlines
- Buy 3 Medical Device Stocks for a Stable Portfolio With Solid UpsideISRG, STE and PLSE offer exposure to AI-enabled medical devices, rising healthcare demand and potential price upside, making them stocks to watch in 2026.NasdaqISRG, STE, PLSE
- Pulse Bio (PLSE) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Pulse Biosciences outlines 15%-25% quarterly non-GAAP expense increase as it targets CE Mark in Q4 2027Seeking Alpha
- Pulse Biosciences Reports Business Updates and Third Quarter 2026 Financial ResultsPulse Biosciences, Inc. announced its business updates and financial results for the third quarter ended September 30, 2026. Cash, cash equivalents, and marketable securities totaled $189.2 million…Nasdaq
- Pulse Biosciences Reports Business Updates and Third Quarter 2026 Financial ResultsHAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™)…Business Wire
- DexCom (DXCM) Surpasses Q3 Earnings and Revenue EstimatesDexCom (DXCM) delivered earnings and revenue surprises of +10.61% and +1.64%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?NasdaqDXCM, PLSE
- Pulse Biosciences Consensus Price Target Increased by 15.43% to $63.58The average one-year price target for Pulse Biosciences (NASDAQCM:PLSE) (DB:6L8) has been revised to $63.58 / share. This is an increase of 15.43% from the prior estimate of $55.08 dated September…NasdaqPLSE, BF.A
- Pulse Biosciences Schedules Third Quarter 2026 Financial Results Conference Call for November 5, 2026HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™)…Business Wire
- Biotech Stocks At 52-Week Highs - MMED +10%, PLSE, SOLV, RPRX, APGE(RTTNews) - The following biotech stocks reached a 52-week high on September 1, 2026, as various companies reported financial results and reached certain regulatory milestones.NasdaqABBV, MMED, PLSE, RPRX